NUCALA – Rheumatology – FEB Display Banners HCP Wallboard Extension – 51979

For patients with gout, urate-lowering therapy (ULT) increases the risk for hospitalizations within the first 6 months of therapy, but reduces the risk in the long-term, according to Mark D. Russell, MD. This is especially the...

Exposure to occupational inhalable agents is associated with an increased risk for anti-citrullinated protein antibodies (ACPA)- positive RA, according to a study published in the Annals of the Rheumatic Diseases. Bowen Tang and...

In the MRIs of patients with rheumatic musculoskeletal diseases (RMD), a high prevalence of foot fractures was observed, even without the presence of osteoporosis, according to a study published in The Journal of Rheumatology....

For patients with RA, the addition of a tumor necrosis factor inhibitor (TNFi) or of sulfasalazine and hydroxychloroquine (triple therapy) to methotrexate results in clinically important improvements in vascular inflammation,...